Previous results (26) regarding women from the same geographical area affected by breast and/or ovarian cancers showed a relatively lower frequency rate of BRCA1/2 PVs (14.8%, 200 out of 1346 probands) compared to males with BC investigated in our study (17%, 17 out of 100 probands). This evidence concerns the gene BRCA1 and ovarian carcinoma.